Canton Strategic Holdings (CNTN) Free Cash Flow (2021 - 2026)
Canton Strategic Holdings posted quarterly Free Cash Flow of -$7.6 million for Q1 2026, down 183.94% year-on-year from $9.1 million in Q1 2025, and up 26.88% on a QoQ basis from -$10.4 million in Q4 2025.
Canton Strategic Holdings (CNTN) has 6 years of Free Cash Flow data on file, last reported at -$7.6 million in Q1 2026.
- For the quarter ending Q1 2026, Free Cash Flow fell 183.94% year-over-year to -$7.6 million; the trailing twelve-month figure through Mar 2026 stood at -$21.1 million (down 95.79% YoY), and the FY2025 full-year result was -$16.1 million, down 47.97% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$7.6 million, up from -$10.4 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$892676.0 in Q4 2022 and bottomed at -$10.4 million in Q4 2025.
- The 5-year median for Free Cash Flow is -$2.2 million (2024), against an average of -$2.9 million.
- The widest annual swing landed in 2022, when Free Cash Flow slumped 11530.96%; it then soared 47.57% in 2025.
- A 5-year view of Free Cash Flow shows it stood at -$892676.0 in 2022, then sank by 58.56% to -$1.4 million in 2023, then tumbled by 114.19% to -$3.0 million in 2024, then sank by 244.42% to -$10.4 million in 2025, then rose by 26.88% to -$7.6 million in 2026.
- The last three Free Cash Flow figures came in at -$7.6 million (Q1 2026), -$10.4 million (Q4 2025), and -$1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | -7.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.64 Mn |
| Mar 31, 2026 | -7.64 Mn |
| Dec 31, 2025 | -10.44 Mn |
| Dec 31, 2025 | -10.44 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | -1.14 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Mar 31, 2025 | -2.69 Mn |
| Dec 31, 2024 | -3.03 Mn |
| Dec 31, 2024 | -3.03 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Sep 30, 2024 | -2.86 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Jun 30, 2024 | -2.18 Mn |
| Mar 31, 2024 | -2.83 Mn |
| Mar 31, 2024 | -2.83 Mn |
| Dec 31, 2023 | -1.42 Mn |
| Dec 31, 2023 | -1.42 Mn |
| Sep 30, 2023 | -908,966.00 |
| Sep 30, 2023 | -908,966.00 |
| Jun 30, 2023 | -1.51 Mn |
| Jun 30, 2023 | -1.51 Mn |
| Mar 31, 2023 | -3.46 Mn |
| Mar 31, 2023 | -3.46 Mn |
| Dec 31, 2022 | -892,676.00 |
| Dec 31, 2022 | -892,676.00 |
| Sep 30, 2022 | -1.55 Mn |
| Sep 30, 2022 | -1.55 Mn |
| Jun 30, 2022 | -1.39 Mn |
| Jun 30, 2022 | -1.39 Mn |
| Mar 31, 2022 | -2.73 Mn |
| Mar 31, 2022 | -2.73 Mn |
| Dec 31, 2021 | -7,675.00 |
| Dec 31, 2021 | -7,675.00 |
| Sep 30, 2021 | -316,776.00 |
| Sep 30, 2021 | -316,776.00 |
| Jun 30, 2021 | -269,423.00 |
| Jun 30, 2021 | -269,423.00 |
| Mar 31, 2021 | -492,370.00 |
| Mar 31, 2021 | -492,370.00 |